Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

NewAmsterdam Pharma (NAMS) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for NewAmsterdam Pharma (NAMS) over the last 2 years, with Q2 2023 value amounting to $1.0.

  • NewAmsterdam Pharma's Shares Outstanding (Weighted Average) changed N/A to $1.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $1.0, marking a year-over-year change of. This contributed to the annual value of $0.98 for FY2022, which is N/A changed from last year.
  • Per NewAmsterdam Pharma's latest filing, its Shares Outstanding (Weighted Average) stood at $1.0 for Q2 2023.
  • NewAmsterdam Pharma's 5-year Shares Outstanding (Weighted Average) high stood at $1.0 for Q2 2023, and its period low was $0.98 during Q4 2022.